ReviveMed Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
ReviveMed is a biotechnology research company based in Cambridge, Massachusetts. It originated as an MIT spinout. The company develops an AI-driven metabolomics platform for precision medicine, with a patented approach that detects roughly 20 times more metabolites per patient than traditional methods, enabling the creation of digital metabolic twins. Digital metabolic twins model an individual's metabolic networks within a multi-omic context to simulate health and disease, with a pipeline focused on oncology and cardio-metabolic diseases such as renal cell carcinoma, MASH, and obesity. The company maintains biopharma partnerships and has worked with 40% of the top-10 pharma, including collaboration with Bristol-Myers Squibb.